Holobiome Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $1.45M
Latest Deal Amount
  • Investors
  • 11

Holobiome General Information

Description

Operator of a biotechnology company intended to develop microbiome-based therapeutics. The company's mental health therapies are driven by compassion for patients and dedicated to scientific rigor, thereby enabling healthcare providers to treat diseases related to the nervous system through microbiome interventions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • One Kendall Square
  • Suite 001, Building 200
  • Cambridge, MA 02139
  • United States
+1 (857) 000-0000

Holobiome Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Holobiome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Grant 24-Sep-2021 $1.45M 00.000 Completed Generating Revenue
13. Grant 06-Jul-2021 00000 00.000 Completed Generating Revenue
12. Later Stage VC 11-Feb-2021 00000 00.000 Completed Generating Revenue
11. Grant 01-Nov-2020 00000 00.000 Completed Generating Revenue
10. Seed Round 17-Oct-2019 00.000 00.000 Completed Generating Revenue
9. Grant 01-Jun-2019 00.000 0000 Completed Generating Revenue
8. Early Stage VC 01-Jan-2019 0000 Completed Generating Revenue
7. Seed Round 28-Dec-2018 00.000 0000 Completed Generating Revenue
6. Accelerator/Incubator 08-Jan-2018 $20K Completed Generating Revenue
5. Early Stage VC 01-Jan-2018 $20K Completed Generating Revenue
To view Holobiome’s complete valuation and funding history, request access »

Holobiome Patents

Holobiome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2019508479-A Modification of the intestinal microbiome to treat mental disorders or diseases of the central nervous system Pending 14-Mar-2016 0000000000
AU-2017234120-A1 Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system Pending 14-Mar-2016 0000000000
EP-3429604-A1 Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system Pending 14-Mar-2016 0000000000
CA-3016911-A1 Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system Pending 14-Mar-2016 0000000000
US-11116804-B2 Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system Active 14-Mar-2016 A61K35/742 00

Holobiome Executive Team (4)

Name Title Board Seat Contact Info
Philip Strandwitz Ph.D Co-Founder, Chief Executive Officer & Board Member
Michael La Fleur Ph.D Co-Founder, President & Board Member
Kim Lewis Ph.D Co-Founder & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Holobiome Board Members (4)

Name Representing Role Since
Iain Chessell Ph.D Self Board Member 000 0000
Kim Lewis Ph.D Holobiome Co-Founder & Board Member 000 0000
Michael La Fleur Ph.D Holobiome Co-Founder, President & Board Member 000 0000
Philip Strandwitz Ph.D Holobiome Co-Founder, Chief Executive Officer & Board Member 000 0000
To view Holobiome’s complete board members history, request access »

Holobiome Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Holobiome Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Corundum Systems Biology Venture Capital Minority 000 0000 000000 0
Argonautic Ventures Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
Alexandria LaunchLabs Accelerator/Incubator Minority 000 0000 000000 0
iSelect Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »